- Home
- HQL vs EVH Comparison
HQL vs EVH Comparison
Compare HQL & EVH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | HQL | EVH |
|---|---|---|
| Founded | 1992 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Other Consumer Services |
| Sector | Finance | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 510.2M | 468.7M |
| IPO Year | N/A | 2015 |
Fundamental Metrics
Financial Performance| Metric | HQL | EVH |
|---|---|---|
| Price | $16.67 | $4.19 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 14 |
| Target Price | N/A | ★ $11.93 |
| AVG Volume (30 Days) | 120.9K | ★ 2.6M |
| Earning Date | 01-01-0001 | 02-19-2026 |
| Dividend Yield | ★ 11.56% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.79 | N/A |
| Revenue | N/A | ★ $2,054,052,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $27.92 |
| P/E Ratio | $17.08 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $11.34 | $3.50 |
| 52 Week High | $14.37 | $12.98 |
Technical Indicators
Market Signals| Indicator | HQL | EVH |
|---|---|---|
| Relative Strength Index (RSI) | 45.23 | 48.82 |
| Support Level | $16.15 | $3.86 |
| Resistance Level | $17.29 | $4.26 |
| Average True Range (ATR) | 0.35 | 0.17 |
| MACD | -0.03 | 0.07 |
| Stochastic Oscillator | 43.80 | 80.00 |
Price Performance
Historical ComparisonAbout HQL abrdn Life Sciences Investors Shares of Beneficial Interest
abrdn Life Sciences Investors operates as a non-diversified closed-end management investment company. Its investment objective is to seek long-term capital appreciation by investing mostly in securities of Life Sciences companies. It invests in securities of public and private companies that are believed by the Fund's Investment Adviser, abrdn Inc to have potential for above-average growth.
About EVH Evolent Health Inc
Evolent Health Inc is engaged in healthcare delivery and payment. The company supports health systems and physician organizations in their migration toward value-based care and population health management. It provides specialty care management services in oncology, cardiology, musculoskeletal markets and holistic total cost of care management along with an integrated platform for health plan administration and value-based business infrastructure under one go to market package. The primary solutions provided by the company include specialty care management services, total cost of care management, and administrative services.